{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:06:05Z","timestamp":1788519965891,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":173,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS104423"],"award-info":[{"award-number":["R01NS104423"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s13311-023-01341-z","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T19:33:51Z","timestamp":1676057631000},"page":"372-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["GABAA Receptor Subtype Specificity in Essential Tremor"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9412-931X","authenticated-orcid":false,"given":"Sheng-Han","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01341-z_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5334\/tohm.632","article-title":"How common is essential tremor? Update on the worldwide prevalence of essential tremor","volume":"11","author":"Louis","year":"2021","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"10.1007\/s13311-023-01341-z_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1212\/WNL.41.2_Part_1.234","article-title":"Essential tremor: clinical correlates in 350 patients","volume":"41","author":"Lou","year":"1991","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01341-z_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fncel.2016.00114","article-title":"Potentiation of gamma aminobutyric acid receptors (GABAAR) by ethanol: how are inhibitory receptors affected?","volume":"10","author":"F\u00f6rstera","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"10.1007\/s13311-023-01341-z_bib4","first-page":"311","article-title":"The future of pharmacotherapies for essential tremor: enhancing GABA neurotransmission or reducing neuronal hyperexcitability?","volume":"163","author":"Kuo","year":"2022","journal-title":"Int Rev Neurobiol"},{"key":"10.1007\/s13311-023-01341-z_bib5","first-page":"1206","article-title":"Essential tremor. BMJ","volume":"2015","author":"Zesiweicz","year":"2015","journal-title":"Clin Evid"},{"key":"10.1007\/s13311-023-01341-z_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/bs.irn.2022.02.007","article-title":"Enhancing GABA inhibition is the next generation of medications for essential tremor","volume":"163","author":"Ondo","year":"2022","journal-title":"Int Rev Neurobiol"},{"key":"10.1007\/s13311-023-01341-z_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5334\/tohm.660","article-title":"The role of the cerebellum in tremor - evidence from neuroimaging","volume":"11","author":"van den Berg","year":"2021","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"10.1007\/s13311-023-01341-z_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41582-019-0302-1","article-title":"Essential tremor pathology: neurodegeneration and reorganization of neuronal connections","volume":"16","author":"Louis","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s13311-023-01341-z_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.5334\/tohm.440","article-title":"Animal models of tremor: relevance to human tremor disorders","volume":"8","author":"Pan","year":"2018","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"10.1007\/s13311-023-01341-z_bib10","volume":"435","author":"Pan","year":"2022","journal-title":"Essential tremor: clinical perspectives and pathophysiology J Neurol Sci"},{"key":"10.1007\/s13311-023-01341-z_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.27443","article-title":"Assembly rules for GABAA receptor complexes in the brain","volume":"6","author":"Martenson","year":"2017","journal-title":"Elife"},{"key":"10.1007\/s13311-023-01341-z_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108338","article-title":"Cerebellum-specific deletion of the GABAA receptor \u03b4 subunit leads to sex-specific disruption of behavior","volume":"33","author":"Rudolph","year":"2020","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-023-01341-z_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pharmrev.121.000293","article-title":"\u03b16-containing GABAA receptors: functional roles and therapeutic potentials","volume":"74","author":"Sieghart","year":"2022","journal-title":"Pharmacol Rev"},{"key":"10.1007\/s13311-023-01341-z_bib14","unstructured":"Huang YH, Lee MT, Hsueh HY, Knutson DE, Cook J, Mihovilovic MD, Sieghart W, Chiou LC, Cerebellar a6GABAA receptors as a therapeutic target for essential tremor: proof-of-concept study with ethanol and pyrazoloquinolinones. Neurotherapeutics, in this issue."},{"key":"10.1007\/s13311-023-01341-z_bib15","doi-asserted-by":"crossref","DOI":"10.5334\/tohm.139","article-title":"Harmaline-induced tremor in mice: videotape documentation and open questions about the model","author":"Cheng","year":"2013","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"10.1007\/s13311-023-01341-z_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2009.05.031","article-title":"Pharmacological characterization of harmaline-induced tremor activity in mice","volume":"616","author":"Paterson","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-023-01341-z_bib17","first-page":"1","article-title":"What's in a name? Nomenclature of essential tremor: syndrome or family of diseases?","volume":"163","author":"Louis","year":"2022","journal-title":"Int Rev Neurobiol"},{"key":"10.1007\/s13311-023-01341-z_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1769","article-title":"Cerebellar oscillations driven by synaptic pruning deficits of cerebellar climbing fibers contribute to tremor pathophysiology","volume":"12","author":"Pan","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1007\/s13311-023-01341-z_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/jn.00100.2020","article-title":"Selective loss of the GABAA\u03b11 subunit from Purkinje cells is sufficient to induce a tremor phenotype","volume":"124","author":"Nietz","year":"2020","journal-title":"J Neurophysiol"},{"key":"10.1007\/s13311-023-01341-z_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1523\/JNEUROSCI.16-01-00103.1996","article-title":"The alpha 6 subunit of the GABAA receptor is concentrated in both inhibitory and excitatory synapses on cerebellar granule cells","volume":"16","author":"Nusser","year":"1996","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-023-01341-z_bib21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5334\/tohm.407","article-title":"Suppression of harmaline tremor by activation of an extrasynaptic GABAA receptor: implications for essential tremor","volume":"8","author":"Handforth","year":"2018","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"10.1007\/s13311-023-01341-z_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/mol.51.4.588","article-title":"Gene knockout of the alpha6 subunit of the gamma-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics","volume":"51","author":"Homanics","year":"1997","journal-title":"Mol Pharmacol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01341-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01341-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01341-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:34:53Z","timestamp":1761806093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1878747923000855"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01341-z","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GABAA Receptor Subtype Specificity in Essential Tremor","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01341-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}